`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owners.
`
`Case IPR2021-00816
`Patent 9,220,631
`
`DECLARATION OF ROBERT T. VLASIS IN SUPPORT OF MOTION
`FOR PRO HAC VICE ADMISSION UNDER 37 C.F.R. § 42.10
`
`
`
`DECLARATION OF ROBERT T. VLASIS IN SUPPORT OF MOTION
`FOR PRO HAC VICE ADMISSION
`
`I, Robert Vlasis, am over eighteen years of age and would be competent to
`
`testify as to the matters set forth herein if called upon to do so.
`
`1.
`
`I am an attorney in the law firm of Weil, Gotshal & Manges LLP. I
`
`have over a decade of experience as a patent litigator and have represented clients
`
`in numerous complex patent litigation cases in various United States District
`
`Courts, and before the Federal Circuit and the U.S. International Trade
`
`Commission. My biography is attached hereto as Ex. 1099.
`
`2.
`
`I am familiar with the subject matter at issue in this proceeding. I am
`
`counsel for Petitioner in the co-pending litigation Novartis Pharma AG, et al., v.
`
`Regeneron Pharmaceuticals, Inc., N.D.N.Y., C.A. No. 3:20-cv-00690, in which
`
`U.S. Patent No. 9,220,631 was asserted in the complaint. I have been intimately
`
`involved with the subject matter at issue since the outset of these proceedings and
`
`the co-pending litigation.
`
`3.
`
`I am a member in good standing of the state bar of Texas, the District
`
`of Columbia, the United States Court of Appeals for the Federal Circuit, and the
`
`United States Supreme Court.
`
`4.
`
`I have not been suspended or disbarred from practice before any court
`
`or administrative body.
`
`1
`
`
`
`5.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`6.
`
`No sanction or contempt citation has been imposed against me by
`
`any court or administrative body.
`
`7.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`8.
`
`I will be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101 et seq. and disciplinary jurisdiction under 37 C.F.R. §
`
`11.19(a).
`
`9.
`
`Within the last three years, I have been admitted pro hac vice before
`
`the Patent Trial and Appeal Board in IPR2018-01670, -01675, -01676, -01678,
`
`-01679, -01680, -01682, -01684, and IPR2019-00122.
`
`I declare under penalty of perjury that the foregoing Declaration is true and
`
`correct; and further that these statements are made with the knowledge that willful
`
`false statements and the like are punishable by fine or imprisonment, or both, under
`
`Section 1001 of Title 18 of the United States Code.
`
`2
`
`
`
`Dated: January 25, 2022
`
`Respectfully submitted,
`
`/Robert T. Vlasis/ 1
`Robert T. Vlasis
`Weil, Gotshal & Manges LLP
`2001 M Street NW, Ste. 600
`Washington, D.C. 20036
`T: 202-682-7000
`robert.vlasis@weil.com
`
`3
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on January 25, 2022, copies of the foregoing
`
`DECLARATION OF ROBERT T. VLASIS IN SUPPORT OF MOTION
`
`FOR PRO HAC VICE ADMISSION was served via electronic mail, upon the
`
`following:
`
`Elizabeth J. Holland
`Linnea Cipriano
` Goodwin Procter LLP
` 620 Eighth Avenue
`New York, NY 10018
`EHolland@goodwinlaw.com
`LCipriano@goodwinlaw.com
`William G. James
` Goodwin Procter LLP
`1900 N Street, N.W.
`Washington, D.C. 20036
`WJames@goodwinlaw.com
`
`Joshua Weinger
`Nicholas K. Mitrokastas
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`JWeinger@goodwinlaw.com
`nmitrokostas@goodwinlaw.com
`
`DG-NovartisPFS@goodwinlaw.com
`
`/Daniela Toribio/
`Daniela Toribio
`IP Paralegal
`Weil, Gotshal & Manges LLP
`2001 M Street, NW, Suite 600
`Washington, D.C. 20036
`daniela.toribio@weil.com
`
`